{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:36:58Z","timestamp":1792157818522,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hrthm.2025.05.039","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T02:53:24Z","timestamp":1747882404000},"page":"3020-3027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The maternal exposure of digoxin and flecainide in relation to the safety and effectiveness in the treatment of non-hydropic fetal tachycardia"],"prefix":"10.1016","volume":"22","author":[{"given":"Rosa M.A.","family":"Smeets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"van Beynum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"van Kesteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me M.J.","family":"Cornette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna A.","family":"van der Zande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien W.","family":"Roos-Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke M.","family":"Beex-Oosterhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-594X","authenticated-orcid":false,"given":"Robert B.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.05.039_bib1","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","article-title":"Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association","volume":"129","author":"Donofrio","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.05.039_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007164","article-title":"First-line antiarrhythmic transplacental treatment for fetal tachyarrhythmia: a systematic review and meta-analysis","volume":"6","author":"Alsaied","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.hrthm.2025.05.039_bib3","first-page":"S53","article-title":"Fetal arrhythmia diagnosis and pharmacologic management","volume":"62","author":"Strasburger","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2025.05.039_bib4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.111.026120","article-title":"Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study","volume":"124","author":"Jaeggi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.05.039_bib5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/pd.5144","article-title":"Transplacental treatment of fetal tachycardia: a systematic review and meta-analysis","volume":"37","author":"Hill","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.hrthm.2025.05.039_bib6","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.hrthm.2014.07.031","article-title":"Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia","volume":"11","author":"Vigneswaran","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.05.039_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/1753495X18808118","article-title":"Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia","volume":"12","author":"Malhame","year":"2019","journal-title":"Obstet Med"},{"key":"10.1016\/j.hrthm.2025.05.039_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jogoh.2017.11.013","article-title":"Maternal complications induced by digoxin treatment of fetal tachycardia: a retrospective series of 18 cases","volume":"47","author":"Moatassim","year":"2018","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.hrthm.2025.05.039_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.3992","article-title":"Transition of maternal serum concentration of digoxin and flecainide in the third trimester-a case report of fetal supraventricular tachycardia with hydrops","volume":"9","author":"Takatsuka","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.hrthm.2025.05.039_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.hrthm.2025.05.039_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00544027","article-title":"Pharmacokinetics of digoxin in pregnancy","volume":"25","author":"Luxford","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2025.05.039_bib12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3476(05)81156-4","article-title":"Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias","volume":"121","author":"Azancot-Benisty","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.hrthm.2025.05.039_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/17512433.2017.1344096","article-title":"Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia","volume":"10","author":"Martin-Suarez","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2025.05.039_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2025.05.039_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.935455","article-title":"Efficacy and safety of various first-line therapeutic strategies for fetal tachycardias: a network meta-analysis and systematic review","volume":"13","author":"Qin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hrthm.2025.05.039_bib16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/adc.55.7.506","article-title":"Prospective study of fetal heart rate and rhythm patterns","volume":"55","author":"Southall","year":"1980","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.hrthm.2025.05.039_bib17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/jce.14406","article-title":"Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience","volume":"31","author":"O\u2018Leary","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.05.039_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jacc.2019.06.024","article-title":"Antenatal therapy for fetal supraventricular tachyarrhythmias: multicenter trial","volume":"74","author":"Miyoshi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.039_bib19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/106002809402800907","article-title":"Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy","volume":"28","author":"Bourget","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hrthm.2025.05.039_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002460010053","article-title":"Unusual electrocardiogram findings in a preterm infant after fetal tachycardia with hydrops fetalis treated with flecainide","volume":"21","author":"Trotter","year":"2000","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.039_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/heart.89.4.470-a","article-title":"Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia","volume":"89","author":"Rasheed","year":"2003","journal-title":"Heart"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125024993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125024993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:05:08Z","timestamp":1778868308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125024993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1547527125024993"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.039","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The maternal exposure of digoxin and flecainide in relation to the safety and effectiveness in the treatment of non-hydropic fetal tachycardia","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}